In conclusion, our preliminary findings provide a pillar for exploring the prognostic value of liquid biopsies for the benefit of PSMA-PET-guided salvage radiotherapy in oligometastatic prostate cancer relapses. This evidence concerns the gene FOLH1 and prostate carcinoma.